The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular <i>Mycobacterium tuberculosis</i> despite impairing T‐cell function

Stephanie Wehrstedt(Institute of Medical Microbiology and Hygiene), Steffen Stenger(University Hospital Ulm)
European Journal of Immunology
September 22, 2018
Cited by 4


Related Papers